| Product Code: ETC9550660 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Cancer Therapy Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Cancer Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Cancer Therapy Market - Industry Life Cycle |
3.4 Sweden Cancer Therapy Market - Porter's Five Forces |
3.5 Sweden Cancer Therapy Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Sweden Cancer Therapy Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Sweden Cancer Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Sweden Cancer Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Sweden |
4.2.2 Technological advancements in cancer therapy |
4.2.3 Growing awareness and focus on early cancer detection and treatment |
4.3 Market Restraints |
4.3.1 High cost associated with cancer therapy |
4.3.2 Stringent regulatory requirements for approval of cancer therapies |
4.3.3 Limited access to advanced cancer treatment facilities in remote areas of Sweden |
5 Sweden Cancer Therapy Market Trends |
6 Sweden Cancer Therapy Market, By Types |
6.1 Sweden Cancer Therapy Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Cancer Therapy Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Sweden Cancer Therapy Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.4 Sweden Cancer Therapy Market Revenues & Volume, By Target Therapy, 2021- 2031F |
6.1.5 Sweden Cancer Therapy Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.1.6 Sweden Cancer Therapy Market Revenues & Volume, By Hormone Therapy, 2021- 2031F |
6.1.7 Sweden Cancer Therapy Market Revenues & Volume, By Other Treatment Types, 2021- 2031F |
6.2 Sweden Cancer Therapy Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Sweden Cancer Therapy Market Revenues & Volume, By Blood Cancer, 2021- 2031F |
6.2.3 Sweden Cancer Therapy Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.4 Sweden Cancer Therapy Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.5 Sweden Cancer Therapy Market Revenues & Volume, By Gastrointestinal Cancer, 2021- 2031F |
6.2.6 Sweden Cancer Therapy Market Revenues & Volume, By Gynecologic Cancer, 2021- 2031F |
6.2.7 Sweden Cancer Therapy Market Revenues & Volume, By Respiratory/Lung Cancer, 2021- 2031F |
6.3 Sweden Cancer Therapy Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Sweden Cancer Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Sweden Cancer Therapy Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 Sweden Cancer Therapy Market Revenues & Volume, By Cancer and Radiation Therapy Center, 2021- 2031F |
7 Sweden Cancer Therapy Market Import-Export Trade Statistics |
7.1 Sweden Cancer Therapy Market Export to Major Countries |
7.2 Sweden Cancer Therapy Market Imports from Major Countries |
8 Sweden Cancer Therapy Market Key Performance Indicators |
8.1 Average survival rate of cancer patients |
8.2 Adoption rate of innovative cancer therapies |
8.3 Number of clinical trials for cancer treatment in Sweden |
9 Sweden Cancer Therapy Market - Opportunity Assessment |
9.1 Sweden Cancer Therapy Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Sweden Cancer Therapy Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Sweden Cancer Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Sweden Cancer Therapy Market - Competitive Landscape |
10.1 Sweden Cancer Therapy Market Revenue Share, By Companies, 2024 |
10.2 Sweden Cancer Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here